Globe Life Inc 8-K, filed Nov 5, 2021
Globe Life Inc. (GL)
8-K
2021-11-05
For: 2021-11-05
View Original
Added on
April 08, 2026
About this 8-K
Globe Life Inc filed this 8-K on November 5, 2021.
Items reported
- Item 5.02: Director or officer change, or executive pay
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 5, 2021 (November 3, 2021)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File No.) | (I.R.S. Employer ID No.) | ||||||||||||
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (972 ) 569-4000
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchanged on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):
| Emerging growth company | ||||||||||||||||||||
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | |||||||||||||||||||
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Other Officers.
(d) On November 3, 2021, pursuant to the By-Laws of Globe Life Inc. (the "Company"), the Board of Directors (the "Board") of the Company voted to expand the number of directors to thirteen persons as of such date. The Board appointed Mark A. Blinn and James P. Brannen to fill the newly created directorships. Mr. Blinn and Mr. Brennan will each serve for an initial term commencing on November 3, 2021 and ending at the beginning of the April 28, 2022 Annual Meeting of Shareholders. There were no understandings or arrangements pursuant to which Mr. Blinn or Mr. Brennan were selected as directors.
Having been determined by the Board to be "independent" pursuant to NYSE rules and additional Company criteria, Mr. Blinn was named to serve on the Audit Committee of the Board and Mr. Brannen was named to serve on the Compensation Committee of the Board.
Mr. Blinn and Mr. Brannen are compensated for their service as directors pursuant to the Amended Globe Life Inc. 2018 Non-Employee Director Compensation Plan (the "Plan"), a sub-plan of the Globe Life Inc. 2018 Incentive Plan. Pursuant to the Plan, each newly-elected director will receive an annual cash retainer of $100,000 prorated for the period of his service (unless a timely election is made to receive an equivalent amount of restricted stock, restricted stock units, or stock options) and an annual equity retainer allowing him to elect to receive $160,000 of restricted stock, restricted stock units, or stock options prorated for the period of his service. As a member of the Audit Committee, Mr. Blinn will also receive an annual cash Audit Committee member retainer of $12,500 (prorated for the period of his service). There are no transactions or currently proposed transactions requiring disclosure pursuant to Item 404(a) of Regulation S-K involving Mr. Blinn or Mr. Brannen.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: | GLOBE LIFE INC. | |||||||||||||
| /s/ Christopher T. Moore | ||||||||||||||
| Christopher T. Moore Corporate Senior Vice President, Associate Counsel and Corporate Secretary | ||||||||||||||